Lot A. Devriese

3.3k total citations
83 papers, 1.7k citations indexed

About

Lot A. Devriese is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology. According to data from OpenAlex, Lot A. Devriese has authored 83 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 22 papers in Otorhinolaryngology. Recurrent topics in Lot A. Devriese's work include Head and Neck Cancer Studies (21 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Oral health in cancer treatment (10 papers). Lot A. Devriese is often cited by papers focused on Head and Neck Cancer Studies (21 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Oral health in cancer treatment (10 papers). Lot A. Devriese collaborates with scholars based in Netherlands, United States and Germany. Lot A. Devriese's co-authors include Stefan M. Willems, Emma J. de Ruiter, Marc Lucas Ooft, Jan H.M. Schellens, Emile E. Voest, Remco de Bree, Jos H. Beijnen, Najiba Chargi, Alwin D. R. Huitema and Suzanne L. Topalian and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Lot A. Devriese

77 papers receiving 1.6k citations

Peers

Countries citing papers authored by Lot A. Devriese

Since Specialization

Citations

This map shows the geographic impact of Lot A. Devriese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lot A. Devriese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lot A. Devriese more than expected).

Fields of papers citing papers by Lot A. Devriese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lot A. Devriese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lot A. Devriese. The network helps show where Lot A. Devriese may publish in the future.

Co-authorship network of co-authors of Lot A. Devriese

This figure shows the co-authorship network connecting the top 25 collaborators of Lot A. Devriese. A scholar is included among the top collaborators of Lot A. Devriese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lot A. Devriese. Lot A. Devriese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	[18F]FDG-PET/CT’s change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial 2025 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), (unknown), Laura A. Smit, Jan Paul de Boer, Arash Navran, Winan J. van Houdt, Remco de Bree, Lot A. Devriese, John B.A.G. Haanen, Maurits Wondergem, Charlotte L. Zuur, Wouter V. Vogel	0
2	Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study 2025 ·Journal of Clinical Oncology ·Shailender Bhatia, Suzanne L. Topalian, William H. Sharfman, Tim Meyer, Neil Steven, Christopher D. Lao, Lorena Fariñas-Madrid, Lot A. Devriese, Kathleen N. Moore, Robert L. Ferris, Yoshitaka Honma, Ileana Elias, Anjaiah Srirangam, Charlie Garnett‐Benson, Michelle Lee, Paul Nghiem	7
3	Change of skeletal muscle mass and associated factors during radiotherapy and chemoradiotherapy in patients with head and neck squamous cell carcinoma 2025 ·Oral Oncology Reports ·(unknown), (unknown), Annemieke Kok, (unknown), Rebecca K. Stellato, Ernst J. Smid, (unknown), Carla H. van Gils, Caroline M. Speksnijder, (unknown), Lot A. Devriese, Remco de Bree	0
4	The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysis 2024 ·Oral Oncology ·(unknown), (unknown), (unknown), (unknown), Ernst J. Smid, Carla H. van Gils, Lot A. Devriese, Remco de Bree	2
5	How do patients with head and neck cancer and low skeletal muscle mass experience cisplatin-based chemoradiotherapy? A qualitative study 2024 ·Supportive Care in Cancer ·(unknown), (unknown), Lot A. Devriese, (unknown), Rainer Grün, Ernst J. Smid, Remco de Bree, Caroline M. Speksnijder	1
6	Differences in the association of time to treatment initiation and survival according to various head and neck cancer sites in a nationwide cohort 2024 ·Radiotherapy and Oncology ·Michael Frank, Boukje A. C. van Dijk, (unknown), Jaap Zindler, Lot A. Devriese, Robert J.J. van Es, Matthias A.W. Merkx, Remco de Bree	2
7	Sinonasal mucosal melanoma in The Netherlands between 2001 and 2021: a clinical and epidemiological overview of 320 cases 2024 ·European Archives of Oto-Rhino-Laryngology ·(unknown), (unknown), Lot A. Devriese, Mischa de Ridder, Marieke W.J. Louwman, Gerben E. Breimer, Remco de Bree, Boukje A. C. van Dijk, Johannes A. Rijken	2
8	The association between skeletal muscle mass and sensorineural hearing loss upon cisplatin‐based chemoradiotherapy in patients with head and neck squamous cell carcinoma 2024 ·Head & Neck ·(unknown), (unknown), (unknown), (unknown), Jan Paul de Boer, Lisette van der Molen, (unknown), Abrahim Al‐Mamgani, Katarzyna Jóźwiak, Lot A. Devriese, Remco de Bree, Charlotte L. Zuur	1
9	Results of a randomized, double-blind, placebo-controlled, phase 2 study (OpcemISA) of the combination of ISA101b and cemiplimab versus cemiplimab for recurrent/metastatic (R/M) HPV16-positive oropharyngeal cancer (OPC). 2024 ·Journal of Clinical Oncology ·(unknown), Kevin J. Harrington, Erminia Massarelli, (unknown), Sonja Visscher, Matthew G. Fury, (unknown), Simon Laban, Jérôme Fayette, Marc Oliva, Lisa Licitra, Bohuslav Melichar, Anthony Kong, Lot A. Devriese, Irene Braña, Petra Jankowska, Marshall R. Posner, Leon Hooftman, Cornelis J.M. Melief, Renata Ferrarotto	9
10	p-mTOR, p-ERK and PTEN Expression in Tumor Biopsies and Organoids as Predictive Biomarkers for Patients with HPV Negative Head and Neck Cancer 2023 ·Head and Neck Pathology ·(unknown), Emma J. de Ruiter, (unknown), Else Driehuis, Lot A. Devriese, Robert J.J. van Es, Stefan M. Willems	4
11	Diagnostic and Treatment-Related Challenges in Sinonasal Teratocarcinosarcoma: A Report of Three Cases 2023 ·SHILAP Revista de lepidopterología ·(unknown), Weibel W. Braunius, Bernard M. Tijink, (unknown), Frank A. Pameijer, Gerben E. Breimer, Ernst J. Smid, Remco de Bree, Lot A. Devriese, Johannes A. Rijken	1
12	Long-term oncological follow-up after mold-based pulsed dose rate brachytherapy for early stage squamous cell carcinoma of the nasal vestibule: A single center experience of 68 patients over a 17-year period 2022 ·Brachytherapy ·(unknown), Homan Dehnad, (unknown), Luuk M. Janssen, Bernard M. Tijink, Gerben E. Breimer, Ernst J. Smid, Lot A. Devriese, Remco de Bree, Mischa de Ridder, Johannes A. Rijken	11
13	Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer 2022 ·Radiotherapy and Oncology ·Reinout H. de Roest, (unknown), Frederik Wesseling, Emma J. de Ruiter, Martijn W. Heymans, Chris H.J. Terhaard, Marije R. Vergeer, Jan Buter, Lot A. Devriese, Jan Paul de Boer, Arash Navran, Ann Hoeben, Conchita Vens, Michiel W. M. van den Brekel, Ruud H. Brakenhoff, C. René Leemans, Frank Hoebers	15
14	Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial 2021 ·Journal for ImmunoTherapy of Cancer ·Robert L. Ferris, William C. Spanos, Rom S. Leidner, Anthony Gonçalvès, Uwe M. Martens, Chrisann Kyi, William H. Sharfman, Christine H. Chung, Lot A. Devriese, Hélène Gauthier, (unknown), Lazar Vujanović, Janis M. Taube, Julie E. Stein, Jun Li, Bin Li, Tian Chen, (unknown), Suzanne L. Topalian	126
15	The association of cisplatin pharmacokinetics and skeletal muscle mass in patients with head and neck cancer: The prospective PLATISMA study 2021 ·European Journal of Cancer ·Najiba Chargi, (unknown), (unknown), Lot A. Devriese, Remco de Bree, Alwin D. R. Huitema	20
16	Eight years of experience with vismodegib for advanced and multiple basal cell carcinoma patients in the Netherlands: a retrospective cohort study 2021 ·British Journal of Cancer ·(unknown), Marlies Wakkee, A.K.L. Reyners, Patty J. Nelemans, Maureen J.B. Aarts, Emöke Rácz, Jorrit B. Terra, Lot A. Devriese, (unknown), Ellen Kapiteijn, Remco van Doorn, Marcel W. Bekkenk, (unknown), Klara Mosterd	12
17	The predictive and prognostic value of low skeletal muscle mass for dose-limiting toxicity and survival in head and neck cancer patients receiving concomitant cetuximab and radiotherapy 2020 ·European Archives of Oto-Rhino-Laryngology ·(unknown), Najiba Chargi, Lot A. Devriese, Pim A. de Jong, Remco de Bree	19
18	Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairment 2012 ·Cancer Chemotherapy and Pharmacology ·Lot A. Devriese, Petronella O. Witteveen, Silvia Marchetti, Marja Mergui‐Roelvink, Larisa Reyderman, J. Wanders, (unknown), G. Edwards, Jos H. Beijnen, Emile E. Voest, Jan H.M. Schellens	37
19	Validation of a multiparameter flow cytometry method for the determination of phosphorylated extracellular‐signal‐regulated kinase and DNA in circulating tumor cells 2012 ·Cytometry Part A ·Dick Pluim, Lot A. Devriese, Jos H. Beijnen, Jan H.M. Schellens	24
20	Drug susceptibility and treatment of Staphylococcus hyicus dermatitis in cattle. 1991 ·The Indian Veterinary Journal ·(unknown), (unknown), (unknown), Lot A. Devriese	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact